S
0.030
0.01 (34.09%)
| Previous Close | 0.022 |
| Open | 0.030 |
| Volume | 46,027 |
| Avg. Volume (3M) | 217,594 |
| Market Cap | 791,558 |
| Price / Sales | 2.10 |
| Price / Book | 10.65 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
| Operating Margin (TTM) | -28,891.71% |
| Diluted EPS (TTM) | -3.07 |
| Current Ratio (MRQ) | 2.25 |
| Operating Cash Flow (TTM) | -100.02 M |
| Levered Free Cash Flow (TTM) | -57.94 M |
| Return on Assets (TTM) | -59.88% |
| Return on Equity (TTM) | -776.96% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bearish | Bearish |
| Biotechnology (Global) | Bearish | Bearish | |
| Stock | Syros Pharmaceuticals, Inc. | Mixed | Bearish |
AIStockmoo Score
-1.1
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -1.13 |
|
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 0.76% |
| % Held by Institutions | 16.32% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| 1492 Capital Management Llc | 31 Mar 2025 | 39,244 |
| Clarius Group, Llc | 31 Mar 2025 | 0 |
| Aster Capital Management (Difc) Ltd | 31 Mar 2025 | 0 |
| Centerpoint Advisors, Llc | 31 Mar 2025 | 0 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |